P53 protein immunohistochemical expression in colonic adenomas with and without associated carcinoma

The American Journal of Gastroenterology
H A SalehP Tabaczka

Abstract

P53 protein immunohistochemical (IHC) expression was investigated in a series of colonic adenomas and carcinomas to determine the p53 immunohistochemical expression of adenomas in general compared with carcinomas, the difference in staining pattern between adenomas with associated carcinoma and those without associated carcinoma, and the difference in p53 staining in the usual adenomas (low-grade dysplasia) compared with those harboring high-grade dysplasia. The study involved a series of 20 adenomas without concurrent carcinoma (group 1 adenoma), 29 adenomas with concurrent carcinoma (group 2 adenoma), and 20 carcinomas. Sections of the paraffin-embedded tissues were stained with DO-7 p53 monoclonal antibody after microwave antigen-retrieval method. Cases with nuclear staining in > or = 20% of the tumor cells were considered positive. Analysis of results showed that 65% of carcinomas and 37% of all adenomas were reactive with p53 IHC staining (p = 0.03). With respect to the adenomas, 30% of group 1 and 41% of group 2 adenomas were reactive for p53 protein (p = 0.42). Our data demonstrate a statistically significant higher p53 expression rate in colonic carcinomas than in adenomas, and that adenomas with concurrent carcinomas a...Continue Reading

References

Mar 12, 1992·International Journal of Cancer. Journal International Du Cancer·M PignatelliW F Bodmer
Jul 2, 1992·Nature·D P Lane
Jun 6, 1991·Nature·A J LevineC A Finlay
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Sep 1, 1988·The New England Journal of Medicine·B VogelsteinJ L Bos
Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Z S ZengA M Cohen
Jan 1, 1994·Gastroenterology·R HamelinG Thomas
Oct 28, 1993·The New England Journal of Medicine·C C Harris, M Hollstein
Jul 1, 1993·Gastroenterology·S R Hamilton
Feb 21, 1996·Journal of the National Cancer Institute·S SjögrenJ Bergh

❮ Previous
Next ❯

Citations

Aug 10, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Janine G EinspahrStanley R Hamilton
Jun 30, 2018·Digestive Diseases and Sciences·Chihiro MinatsukiKazuhiko Koike

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.